Key Points Rescheduling could expand Tilray’s U.S. medical cannabis opportunity. U.S. cannabis operators could benefit more immediately from rescheduling. Tilray looks stronger, but federal reform remains uncertain. 10 stocks we like better than Tilray Brands › President Donald Trump directed federal officials to move quickly on marijuana rescheduling, and that effort just survived another legal challenge. Last week, a federal appeals court rejected a request from marijuana opponents to temporarily block the administration from moving forward with broader rescheduling while their lawsuits are considered.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。